India’s Right to Produce Low-Cost, Life Saving Drugs Challenged by Big Pharma

Patients Before Patents, Groups Urge

By Stephen Leahy

Jan 29 (IPS) – A quarter of a million people from over 150 countries don’t think a multinational drug company should seek to overturn a provision of India’s patent law that permits the manufacture of low-cost life-saving drugs for the world’s poor.

Swiss pharmaceutical giant Novartis AG went to India’s High Court Monday to challenge India’s new patent laws despite months of pressure from health organisations working in the developing world.
Continue reading